Learn, Analyse & Invest
only with
only with
+91
Download Orca
Purple Finance Ltd.
Purple Finance
Purple Finance Ltd. live price is ₹ 0.00. Price change 0.00, 0.00 percent.
₹ 0.00
0.00 (0.00)%
Finance
Small-cap - With a market cap of ₹4.88 Cr.
| EX-Date | Purpose |
|---|---|
| 20 09 2024 | Right Issue of Equity Shares |
| 25 10 2024 | Quarterly Results |
| 19 01 2025 | Quarterly Results & Inter alia, shall also consider the proposal for raising of fund by way of equity shares or any other securities through rights issue, qualified institutions placement, preferential issue or any other method as may be permitted under the applicable law, subject to such regulatory/ statutory approvals as may be required |
| 19 01 2025 | Quarterly Results |
| 28 02 2025 | Inter alia, to consider and approve:- 1. The proposal for raising funds by way of equity shares or other securities through rights issue, qualified institutions placement, preferential issue or any other method as may be permitted under the applicable law, subject to such regulatory / statutory approvals as may be required. 2. The increase in the authorized share capital of the Company. 3. Fix date, time and venue for convening the Extra- Ordinary General Meeting of the Company. |
| 20 03 2025 | Right Issue of Equity Shares & Audited Results |
| 21 04 2025 | Audited Results |
| 15 05 2025 | Inter alia, to consider and approve:- 1. The Management Discussion and Analysis Report (MDAR) for the Financial Year 2024-25. 2. The Directors Report and its annexures for the Financial Year 2024-25. 3. The increase in the Authorized Share Capital of the Company. 4. The terms and conditions and other related matters in connection with the Rights Issue of Equity Shares, including the determination of Rights Issue price and related payment mechanism, issue size, rights entitlement ratio, record date, Issue opening and closing date, etc. and to approve the Letter of Offer and other related documents. 5. To consider and fix date, time and venue for convening the 31st Annual General Meeting of the Company. |
| 21 07 2025 | Quarterly Results |
| 14 08 2025 | Inter alia, to consider and approve:- (1) The proposal for raising funds by way of Equity Shares, Debentures or other securities through rights issue, qualified institutions placement, preferential issue or any other method as may be permitted under the applicable law, subject to such regulatory / statutory approvals as may be required. |
| 17 10 2025 | Quarterly Results |
| 28 10 2025 | Inter alia, to consider and approve the proposal for fund raising by way of Issuance of Securities namely Equity Shares, Preference Shares, Warrants, Debentures or other securities through rights issue, qualified institutions placement, preferential issue or any other method as may be permitted under the applicable law. |
| 24 12 2025 | Inter alia, to consider and approve:- (1) the proposal for fund raising by way of Issuance of Securities namely Equity Shares, Preference Shares, Warrants, Debentures or other securities through rights issue, qualified institutions placement, preferential issue or any other method as may be permitted under the applicable law, subject to such regulatory / statutory approvals as may be required and the approval of shareholders of the Company. |
| 21 01 2026 | Quarterly Results |
| 06 02 2026 | Inter alia, to consider and approve:- (1) the proposal for fund raising by way of Issuance of Securities namely Equity Shares, Preference Shares, Warrants, or other securities through rights issue, qualified institutions placement, preferential issue or any other method as may be permitted under the applicable law, subject to such regulatory / statutory approvals as may be required and the approval of shareholders of the Company. |
| 24 03 2026 | Inter alia, to consider and approve the proposal for fund raising by way of Issuance of Securities namely Equity Shares, Preference Shares, Warrants, Debentures or other securities through rights issue, qualified institutions placement, preferential issue or any other method as may be permitted under the applicable law, subject to such regulatory / statutory approvals as may be required and the approval of shareholders of the Company. |
| 31 03 2026 | Inter alia, to consider and approve:- (1) proposal for fund raising by way of Issuance of Securities namely Equity Shares, Preference Shares, Warrants, Debentures or other securities through rights issue, qualified institutions Placement, preferential issue or any other method as may be permitted under the applicable law, subject to such regulatory / statutory approvals as may be required and the approval of shareholders of the Company. |
| 21 04 2026 | Quarterly Results & Audited Results |
| 21 07 2026 | Quarterly Results & Inter alia, to consider and approve:- i. Fund raising by way of Issuance of Securities namely Equity Shares, Preference Shares, Warrants, Debentures or other securities through rights issue, qualified institutions placement, preferential issue or any other method as may be permitted under the applicable law, subject to such regulatory / statutory approvals as may be required and the approval of shareholders of the Company. |
| 06 08 2026 | Inter alia to consider and evaluate the proposal for fund raising by way of issuance of securities namely equity shares, preference shares, warrants, or other eligible securities through one or more permissible modes including by way of rights issue, qualified institutions placement, preferential issue or any other method as may be permitted under the applicable laws, subject to such regulatory/ statutory approvals as may be required and the approval of Members of the Company. Further, we wish to inform you that the Company proposes to seek the approval of its members for the said proposal, if required, by way of a Postal Ballot or an Extraordinary General Meeting and the same shall be intimated in due cours |